IPCA Laboratories · NSE: IPCALAB · BSE: 524494
Q2 FY19 results · Jul–Sep 2018
IPCA Laboratories reported revenue from operations of ₹997.82 crore and net profit of ₹119.74 crore for Q2 FY19 (Jul–Sep 2018), on a standalone basis.
| Item | Q2 FY19 | Q2 FY18 | YoY | Q1 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 997.82 | — | — | 853.93 | +16.9% |
| Other income | 13.75 | — | — | 13.63 | +0.9% |
| Total income | 1,011.57 | — | — | 867.56 | +16.6% |
| Profit before tax | 141.00 | — | — | 78.22 | +80.3% |
| Net profit for the period | 119.74 | — | — | 65.52 | +82.8% |
| EPS, basic (₹) | 9.48 | — | — | 5.19 | +82.7% |
| Net margin (%) | 12.0 | — | 7.7 |
Standalone
- Filed with BSE
- 14 Nov 2018, 18:36 IST
- Board meeting
- 14 Nov 2018
- Period
- 01 Jul 2018 to 30 Sep 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE